| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/16/2007 | EP1785145A1 Transnasal composition having immediate action and high absorbability |
| 05/16/2007 | EP1785144A2 Combinations of bile acids sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 05/16/2007 | EP1785139A1 Antagonist against tolerance to anticancer drugs |
| 05/16/2007 | EP1785136A2 Inhalation medicaments containing an anticholinesterase drug in conjunction with corticosteroid and betamimetic drugs |
| 05/16/2007 | EP1785131A1 External preparation of s/o type |
| 05/16/2007 | EP1784224A2 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 05/16/2007 | EP1784223A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 05/16/2007 | EP1784201A2 Physiologically active composition |
| 05/16/2007 | EP1465638B1 Phosphate transport inhibitors |
| 05/16/2007 | EP1390406B1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 05/16/2007 | EP1303307B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 05/16/2007 | EP1169340B1 Lantibiotic |
| 05/16/2007 | EP1165603B1 Human neurogenin 3-encoding nucleotide sequences |
| 05/16/2007 | EP1140136B1 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 05/16/2007 | EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury |
| 05/16/2007 | EP0789567B1 A method for treating vascular headaches |
| 05/16/2007 | CN1964742A Combination therapy with azd2171 and 5-fu and/or cpt-11 |
| 05/16/2007 | CN1964741A Methods of using molecules related to organic cation transporter 3 (OCT3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 05/16/2007 | CN1964739A Uses of anti-CTLA-4 antibodies |
| 05/16/2007 | CN1964723A Agent for visualizing transparent tissue |
| 05/16/2007 | CN1964709A Memory fixation accelerator |
| 05/16/2007 | CN1964707A Antitumor effect fortifier, antitumor agent and method of therapy for cancer |
| 05/16/2007 | CN1961974A Nano copolymer fibrous membrane material capable of being biodegraded and absorbed and preparation process and use thereof |
| 05/16/2007 | CN1961880A Cancer treatment. |
| 05/16/2007 | CN1961864A Anticancer composition |
| 05/16/2007 | CN1961863A An anticancer sustained releasing agent containing mesenchyme hydrolytic reagent and cytotoxic drug |
| 05/16/2007 | CN1961862A Compound anticancer sustained releasing agent containing mesenchyme hydrolytic reagent |
| 05/16/2007 | CN1961861A An anticancer sustained releasing agent |
| 05/16/2007 | CN1961860A A solid tumor resistant tumor |
| 05/16/2007 | CN1315867C 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 05/16/2007 | CN1315835C Polycyclic guanine phosphodiesterase v inhibitors |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315803C Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 05/16/2007 | CN1315478C Composition for improving implantation rates after vitro fertilization and pharmaceutical use thereof |
| 05/15/2007 | US7217811 Human gene critical to fertility |
| 05/15/2007 | US7217738 β2-adrenergic receptor agonists |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | US7217730 Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus |
| 05/15/2007 | US7217720 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; treatment of conditions caused by androgen deficiency |
| 05/15/2007 | US7217718 Administering an immunosuppressant; therapy for autoimmune disease |
| 05/15/2007 | US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses |
| 05/15/2007 | US7217710 Pyrazolo-pyrimidine compound; anticancer agents |
| 05/15/2007 | US7217705 synergistic effect; CB1 receptor antagonist is an azetidine compound of given formula such as N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide, and the dopaminergic agent is ropinirole or levodopa for example |
| 05/15/2007 | US7217700 Chemokines as adjuvants of immune response |
| 05/15/2007 | US7217692 Complex of a human FOXC2 protein and a FOXC2-interacting protein |
| 05/15/2007 | US7217687 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 05/15/2007 | US7217555 isolated human NAALAD-ase (N-acetylated alpha-linked acidic dipeptidases) L protein; |
| 05/15/2007 | US7217534 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 05/15/2007 | US7217418 Administering an attenuated dengue-1 (DEN-1) virus composition |
| 05/15/2007 | US7217416 Use of gamma globulin for the topical treatment of lesions of dermatitis |
| 05/15/2007 | US7217413 Use of novel agents inducing cell death in synergy with interferons |
| 05/15/2007 | US7217412 IL-17C related mammalian cytokine polypeptides |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2325739C Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator |
| 05/15/2007 | CA2294337C Preparation of pharmaceutical compositions |
| 05/15/2007 | CA2281944C Methods and compositions for preventing and treating chronological aging in human skin |
| 05/15/2007 | CA2255540C Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/15/2007 | CA2176948C Chaperonin 10 |
| 05/15/2007 | CA2134961C Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses |
| 05/15/2007 | CA2065414C Treatment of autoimmune disease |
| 05/10/2007 | WO2007053773A1 Compositions and methods using nicotinic acid for treatment of hypercholesterolemia, hyperlipidemia and cardiovascular disease |
| 05/10/2007 | WO2007053406A1 Combinations of antihypertensive and cholesterol lowering agents |
| 05/10/2007 | WO2007053384A1 Dispensing brush with replaceable cartridge/handle part |
| 05/10/2007 | WO2007052850A1 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
| 05/10/2007 | WO2007052849A1 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
| 05/10/2007 | WO2007052837A1 Gastrointestinal function promoter |
| 05/10/2007 | WO2007052561A1 Method for prevention of myocardial hypertrophy by inhibiting interaction between slim1 and usp, and agent for prevention of myocardial hypertrophy |
| 05/10/2007 | WO2007052398A1 Method of screening compound useful in treating allergic disease |
| 05/10/2007 | WO2007051862A1 Combination of organic compounds |
| 05/10/2007 | WO2007051594A1 Treatment of diabetes |
| 05/10/2007 | WO2007029642A9 Remedy for osteoporosis with the use of retinoid x receptor-related compound |
| 05/10/2007 | WO2007025286A3 Therapy procedure for drug delivery for trigeminal pain |
| 05/10/2007 | WO2007016108B1 Compositions for affecting weight loss |
| 05/10/2007 | WO2006124477A3 Combination therapy with inhibitors of hmgb and caspase for the treatment of inflammatory diseases |
| 05/10/2007 | WO2006123178A3 Methods and compositions for the treatment of viral diseases |
| 05/10/2007 | WO2006067310A3 Use of a dihydroim1dazopyrazine derivative for treating or preventing pain |
| 05/10/2007 | WO2004082637A3 Combination of an aldosterone receptor antagonist and an endothelin receptor antagonist and/or endothelin converting enzyme inhibitor |
| 05/10/2007 | US20070106087 Therapeutic Malonic Acid/Acetic Acid C60 Tri-Adducts of Buckminsterfullerene and Methods Related Thereto |
| 05/10/2007 | US20070106076 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino [1,2-a] indoles |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105913 Alkynyl aryl carboxamides |
| 05/10/2007 | US20070105910 Medicinal composition |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070105897 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/10/2007 | US20070105894 Combination of at least two compounds selected from an AT1-receptorantagonist or an ACE inhibitor or a HMG-Co-A reductase inhibitor |
| 05/10/2007 | US20070105886 Steroidal compounds for inhibiting steroid sulphatase |
| 05/10/2007 | US20070105843 Combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 05/10/2007 | US20070105796 Method for inhibiting telomerase activity and inhibitor thereof |
| 05/10/2007 | US20070105785 Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators |
| 05/10/2007 | US20070105753 Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070105167 Virulence Associated Nucleic Acid Sequences and Uses Thereof |
| 05/10/2007 | US20070105153 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility |
| 05/10/2007 | US20070105143 Novel bHLH type transcription factor genes |
| 05/10/2007 | US20070104796 Use of xenon with hypothermia for treating neonatal asphyxia |
| 05/10/2007 | US20070104786 Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
| 05/10/2007 | US20070104776 Drug having regulatory cell ligand contained in liposome |
| 05/10/2007 | US20070104770 Methods and Compositions For Topical Wound Treatment |
| 05/10/2007 | US20070104719 Caspase Activated Prodrugs Therapy |
| 05/10/2007 | US20070104714 Composition and method for the treatment of cancer and other physiologic conditins based on modulation of the ppar-gamma pathway and her-kinase axis |